Fresenius Will Pay $250M to Settle GranuFlo Lawsuits
It is a great day for our clients and American consumers in general. The attorneys at The Michael Brady Lynch Firm worked tirelessly for years to make sure those affected by GranuFlo would receive justice. Today, they got it! Manufacturer, Fresenius, has agreed to pay $250 million to GranuFlo’s victims. Plaintiffs must agree to the
Read MoreMichael Brady Lynch to Lecture on GranuFlo and NaturaLyte
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. As my regular readers are aware, I recently issued a Consumer Alert! Dialysis Warning regarding the public health disaster involving the GranuFlo and NaturaLyte dialysis additive products. The U.S. Food & Drug Administration (FDA) has declared Fresenius Medical Care’s recent warning
Read MoreDialysis Product GranuFlo Recalled Due to Deadly Heart Risks
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Each year, approximately 400,000 patients receive dialysis treatment in the United States. As one-third of these treatments utilize products manufactured by Fresenius Medical Care, one would assume that Fresenius is a trusted name in the dialysis industry. However, that could not
Read More